Is NCT07287176 recruiting in New York, NY?

Yes, NCT07287176 is currently recruiting participants at its New York, NY location. This thyroid nodule clinical trial is actively enrolling qualified participants.

How do I join the thyroid nodule clinical trial in New York?

To join this clinical trial in New York, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this New York clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Thyroid Nodule Clinical Trial in New York, NY

About This Thyroid Nodule Study in New York

The primary objective of this study is to reproduce in a multi-center study results obtained during the feasibility First-In-Human (FIH) study with Prof. Stefano Spiezia, MD (Ospedale del Mare, Naples, Italy) and to monitor additional thyroid-related symptoms and impact of patients quality of life post-ablation using a validated QoL questionnaire.

Sponsor: Pulse Biosciences, Inc.

Who Can Participate

Inclusion Criteria

Participant is willing and able to provide voluntary, written informed consent to participate in this study and from whom written informed consent has been obtained

Participants must be willing and able to comply with study procedures including all follow-up visits

Selected nodule is amenable to trans-isthmus approach

Nodule is confirmed as benign based on results from one or more of the following diagnostic tests:

(Bethesda II) on at least 2 ultrasound guided fine needle aspirations (FNA) or core needle biopsy (CNB);

A single benign diagnosis of FNA or CNB when the nodule has benign ultrasound features \[American College of Radiology (ACR) Thyroid Imaging Reporting \& Data System \[TI-RAD\] TR 1-3, American Thyroid Association \[ATA\] very low suspicion\];

Candidate has a hyperfunctional nodule following 1 ultrasound guided FNA or CNB with or without molecular testing; or

Benign (Bethesda III or IV) with two biopsies in addition to molecular testing confirming benign diagnosis

Selected nodule is \<80.0 ml

Participant has normal vocal cord mobility by ultrasound evaluation

Participant has presence of compression symptoms, cosmetic concerns or anxiety for which participant requests treatment of the benign thyroid nodule

Participant has a solitary thyroid nodule or dominating nodule that is well-defined in multinodular goiter

Exclusion Criteria

Participant has an implantable electronic medical device. (i.e., pacemaker, implantable cardioverter defibrillator)

Participant has cystic nodules (\< 70% solid components)

Participant has calcified nodules

Participant is known to be immune compromised

Participant had previous neck irradiation

Participant has abnormal cervical lymph nodes present during screening visit examination

Participant has history of familial thyroid cancer in more than two first-degree relatives

Selected nodule previously treated with radiofrequency ablation or ethanol. This does not apply to nodules previously treated with nanosecond Pulsed Field Ablation (nsPFA)

Participants currently suffering from a hematological disease or bleeding tendency

Selected nodule likely to be in contact with the recurrent laryngeal nerve on ultrasound evaluation

Participant has a history of uncontrolled cardiac arrhythmia, uncontrolled hypertension, chronic liver disease or chronic kidney disease (Stage 4-5), or recent history of myocardial infarction or structural heart disease as determined by the Investigator

Participant has abnormal contralateral vocal cord function

Anesthesia drug allergies

Participant is pregnant at the time of screening or within 30 days prior to enrollment

Participant has any condition or situation which, in the Investigator's opinion, puts the participant at significant risk, could confound the study results, or may interfere significantly with the participant's participation in the study

Use of any investigational device or drug within 30 days prior to enrollment that may confound the results of this study

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07287176) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Thyroid Nodule Treatment Options in New York, NY

If you're searching for thyroid nodule treatment options in New York, NY, this clinical trial (NCT07287176) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thyroid nodule specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all thyroid nodule clinical trials near you to find additional studies recruiting in your area.

Thyroid Nodule Clinical Trial in New York, NY

Expert Care in New York

IRB Approved

No-Cost Care

Apply for This New York Location

Why Participate?

Simple Process